Archive for the ‘Achaogen’ Category

Trius shares surge as antibiotic matches Zyvox in pivotal PhIII

December 19th, 2011 John Carroll

Shares of Trius Therapeutics ($TSRX) surged on the news that its late-stage antibiotic tedizolid closely matched Zyvox (linezolid) in one of a series of pivotal studies, helping nail down support for its case that the experimental antibiotic is just as…

Posted in Achaogen, antibiotic, Blog, Clinical Trial Results, Companies, Diagnostics, Funding, Medical Devices, Medical Supply, Pharmaceuticals, Rib-X Pharmaceuticals, Startups, tedizolid, Tetraphase Pharmaceuticals, Trius Therapeutics, Universities, Videos Tags: Comments Off
Read More »